AGM/EGMMay 8, 2026, 04:12 PM
enGene Therapeutics Announces Annual General Meeting on June 9, 2026
AI Summary
enGene Therapeutics Inc. announced its Annual General Meeting of Shareholders will be held virtually on June 9, 2026, at 8:30 a.m. Eastern time. Shareholders will vote on receiving the audited financial statements for the year ended October 31, 2025, electing four director nominees, and appointing KPMG LLP as the company's auditor. The record date for shareholders entitled to vote is April 28, 2026, and voting instructions are provided for both registered and beneficial owners.
Key Highlights
- Annual General Meeting (AGM) to be held virtually on June 9, 2026, at 8:30 a.m. Eastern time.
- Shareholders will consider audited financial statements for the year ended October 31, 2025.
- Four director nominees will be elected to serve until the 2029 annual meeting.
- KPMG LLP will be appointed as the Company's auditor, with directors authorized to approve remuneration.
- Record Date for voting eligibility is April 28, 2026.
- Shareholders can vote by mail, telephone, internet, or during the virtual meeting.
Price Impact
More from ENGN